Embold Fibered
Payments companies reported to CMS as associated with Embold Fibered. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Embold Fibered, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Embold Fibered
These are the largest totals companies reported as associated with Embold Fibered. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Juan Gimenez | New Orleans, LA | Vascular & Interventional Radiology | $52,324.90 |
| Osmanuddin Ahmed | Chicago, IL | Diagnostic Radiology | $32,202.50 |
| Christopher Grilli | Newark, DE | Vascular & Interventional Radiology | $13,241.34 |
| Joshua Kuban | Houston, TX | Vascular & Interventional Radiology | $11,346.01 |
| Aaron Fischman | New York, NY | Vascular & Interventional Radiology | $7,085.83 |
| Tyler Sandow | New Orleans, LA | Vascular & Interventional Radiology | $6,691.79 |
| Daniel Harwood | Saint Louis, MO | Diagnostic Radiology | $4,273.60 |
| Abhishek Kumar | Philadelphia, PA | Vascular & Interventional Radiology | $3,138.36 |
| Gary Siskin | Albany, NY | Vascular & Interventional Radiology | $2,907.22 |
| Nima Kokabi | Atlanta, GA | Vascular & Interventional Radiology | $1,837.06 |
Prescribed Embold Fibered?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.